Latest

Market news by symbol, source, and language

20 stories
tradingview

20/20 Biolabs Received Notice of Noncompliance

On July 17, 2026, the company received notice from Nasdaq that it is not in compliance with the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2) after its stock closed below $1.00 for 30 consecutive business days from June 3 to July 16, 2026. The company has 180 days, until January…

TradingView en_IN
StocksUS
tradingview

20/20 Biolabs and Streeterville Set 120-Day Standstill on Series E Conversions

20/20 Biolabs entered into a Standstill Agreement with Streeterville Capital to temporarily limit conversions of Series E convertible preferred stock. For 120 days from July 16, 2026, Streeterville will not convert shares unless the common stock trades at least 10% above Nasdaq Rule 5635's Minimum…

TradingView en_IN
StocksUS
stockstory

QCR Holdings (NASDAQ:QCRH) Misses Q2 CY2026 Sales Expectations

Midwest regional bank QCR Holdings (NASDAQGM:QCRH) fell short of the market’s revenue expectations in Q2 CY2026 as sales rose 3% year on year to $97.34 million. Its non-GAAP profit of $2.19 per share was 14.9% above analysts’ consensus estimates.QCR Holdings (QCRH) Q2 CY2026 Highlights:“We delivere…

Stock Story en_IN
StocksUS
tradingview

NETSTREIT Corp. Q2 2026: Revenue $61.3M, EPS $0.06— 10-Q Summary

NETSTREIT Corp. reported second-quarter 2026 results with revenue of $61.3M, net income attributable to common stockholders of $6.29M and diluted EPS of $0.06, each improving versus the year-ago quarter.Financial HighlightsBusiness HighlightsOriginal SEC Filing: NETSTREIT Corp. [ NTST ] - 10-Q - Ju…

TradingView en_IN
StocksUS
business_wire

WEX Inc. Reports Second Quarter 2026 Financial Results

WEX (NYSE: WEX), a global leader in intelligent payment solutions, today reported financial results for the three months ended June 30, 2026.“We are continuing to build momentum, exceeding our guidance ranges once again in the second quarter while advancing our strategic initiatives to accelerate o…

BusinessWire en_IN
StocksUS
tmx_newsfile

Hemostemix Grants Stock Options

Calgary, Alberta--(Newsfile Corp. - July 22, 2026) - Hemostemix Inc. TSXV:HEM (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce that in accordance with its stock option plan, it has granted on July 22, 2026, subject to regulatory approval, a total of 6,280,000 option…

TMX Newsfile en_IN
StocksCA
NEWS miranda_partners

FEXI21 Conference Call 2Q26

FIBRA EXI CORDIALLY INVITES YOU TO JOIN ITS2Q26 EARNINGS CONFERENCE CALLFEXI21 will release its 2Q26 report after market close onThursday, July 30th, 2026Webcast Details:Friday, July 31st, 2026.12:00 P.M. Eastern Time.10:00 A.M. Mexico City.Please  register in advance for this webinar to be able to…

Miranda Partners en_IN
StocksMX
globenewswire

CVB Financial Corp. Announces Appointment of New Director

ONTARIO, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- CVB Financial Corp. NASDAQ:CVBF, the holding company for Citizens Business Bank, National Association, (the “Bank”), is pleased to announce the appointment of Michael J. Maddox as a Director of CVBF. Mr. Maddox has also been appointed to the Board…

GlobeNewswire en_IN
StocksUS
stockstory

SEI Investments’s (NASDAQ:SEIC) Q2 CY2026 Sales Top Estimates

Financial technology provider SEI Investments NASDAQ:SEIC beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 14.7% year on year to $641.6 million. Its non-GAAP profit of $1.66 per share was 15.5% above analysts’ consensus estimates.SEI Investments (SEIC) Q2 CY2026 Highlights:Compan…

Stock Story en_IN
ETFsStocksUS